“The big, inspiring A.I. opportunity on the horizon, experts
agree, lies in accelerating and transforming scientific discovery and
development. Fed by vast troves of scientific data, A.I. promises to generate
new drugs to combat disease, new agriculture to feed the world’s population and
new materials to unlock green energy — all in a tiny fraction of the time of
traditional research.
Technology companies like Microsoft and Google are making
A.I. tools for science and collaborating with partners in fields like drug
discovery. And the Nobel Prize in Chemistry last year went to scientists using
A.I. to predict and create proteins.
This month, Lila Sciences went public with its own ambitions
to revolutionize science through A.I. The start-up, which is based in Cambridge,
Mass., had worked in secret for two years “to build scientific
superintelligence to solve humankind’s greatest challenges.”
Relying on an experienced team of scientists and $200
million in initial funding, Lila has been developing an A.I. program trained on
published and experimental data, as well as the scientific process and
reasoning. The start-up then lets that A.I. software run experiments in
automated, physical labs with a few scientists to assist.
Already, in projects demonstrating the technology, Lila’s
A.I. has generated novel antibodies to fight disease and developed new
materials for capturing carbon from the atmosphere. Lila turned those
experiments into physical results in its lab within months, a process that most
likely would take years with conventional research.”
Komentarų nėra:
Rašyti komentarą